Its also ethical approval for an extension of trial from the same hospital where the trial has been taking place. They wouldnt give this if they didnt think it was worthwhile.
- Forums
- ASX - By Stock
- Ann: Phase 1B brain cancer clinical trial approved for initiation
CHM
chimeric therapeutics limited
Add to My Watchlist
33.3%
!
0.4¢

Its also ethical approval for an extension of trial from the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $12.99M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $949 | 312.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
70 | 67782438 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 91927011 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
70 | 67782438 | 0.003 |
26 | 26746044 | 0.002 |
13 | 54414000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 91927011 | 27 |
0.005 | 33248062 | 21 |
0.006 | 17929018 | 21 |
0.007 | 6512518 | 7 |
0.008 | 7317101 | 5 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |